Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Pancreatic Ductal Adenocarcinoma
100%
Pancreatic Cancer
61%
Gemcitabine
34%
Tumorigenesis
30%
Metastatic Pancreatic Ductal Adenocarcinoma
27%
Chemotherapy
23%
Oncogenic Ras
23%
Nab-paclitaxel
22%
RalA
19%
Tumor
19%
In Cancer
19%
Pancreatic Duct Cells
18%
Overall Survival
18%
KRAS-mutant Cancer
17%
Tumor Growth
17%
Patient-derived Xenograft
17%
CCR2
17%
Transcriptome
17%
Extracellular Signal-regulated Kinase
17%
IRAK4
17%
Human Cells
16%
Tumor Maintenance
14%
Poor Prognosis
13%
Gemcitabine/nab-paclitaxel
13%
K-Ras
13%
Pancreatic Adenocarcinoma
13%
FOLFIRINOX
13%
Human Cancer
12%
Oncogene
12%
Gastrointestinal Cancer
12%
RalB
12%
Tumor-associated Macrophages
12%
Cancer-associated Fibroblasts
12%
5-fluorouracil/leucovorin
12%
Tumor Cells
11%
Chemoresistance
11%
Pembrolizumab
11%
Metastatic Colorectal Cancer (mCRC)
11%
Liposomal Irinotecan
11%
Treatment Strategy
11%
Hepatic Artery Infusion Pump
11%
Ulixertinib
11%
Randomized Phase II Trial
11%
Defactinib
11%
Clinical Update
11%
Phase Ib Study
11%
Progression-free Survival
10%
ERBB2
10%
Hepatocellular Carcinoma
10%
Dose Escalation
10%
Medicine and Dentistry
Pancreas Cancer
77%
Pancreas Adenocarcinoma
68%
Chemotherapy
42%
Diseases
37%
Gemcitabine
35%
Overall Survival
27%
Progression Free Survival
26%
Ras Signaling
22%
Neoplasm
22%
Immunotherapy
20%
Carcinogenesis
19%
Clinical Trial
19%
Cancer
19%
Paclitaxel
18%
Adenocarcinoma
18%
Nivolumab
17%
Malignant Neoplasm
16%
Tumor
15%
Fluorouracil
15%
Folinic Acid
15%
Stroma
14%
Cholangiocarcinoma
14%
Radiation Therapy
13%
Hepatocellular Carcinoma
11%
Intraarterial Drug Administration
11%
Common Hepatic Artery
11%
Interleukin 1 Receptor Associated Kinase 4
11%
Rectum Cancer
11%
Pembrolizumab
11%
Arm
11%
Oxaliplatin
10%
Janus Kinase 1
9%
Focal Adhesion Kinase
9%
Irinotecan
9%
Metastatic Carcinoma
9%
Gallbladder Cancer
8%
Colorectal Carcinoma
8%
Small GTPase
8%
Systemic Therapy
7%
Targeted Therapy
7%
Genetics
7%
Gastrointestinal Cancer
7%
Recurrent Disease
7%
Nuclear Factor
7%
Alternative Complement Pathway C3 C5 Convertase
7%
Mitogen-Activated Protein Kinase
7%
Biliary Duct Cancer
7%
FOLFOX
7%
Colorectal Liver Metastasis
7%
Treatment Option
6%
Biochemistry, Genetics and Molecular Biology
Carcinogenesis
64%
KRAS
46%
Kinase
35%
Phosphotransferase
35%
Genomics
33%
Drive
26%
Fibroblast
23%
Mitogen-Activated Protein Kinase
18%
Drug Resistance
17%
Transcriptome
17%
Interleukin-1 Receptor-Associated Kinase
17%
Cancer Cell
15%
Protein Kinase B
14%
Tumor Progression
14%
Immunocompetent Cell
13%
Oncogene
13%
IRAK4
12%
Proteomics
12%
Stromal Cell
11%
Cell Survival
11%
RNA Sequence
11%
Interleukin-1
10%
Tumor Initiation
9%
Small GTPase
9%
phosphorylation
9%
Epidermal Growth Factor Receptor
9%
Genetics
8%
Transcription Factors
8%
Vascularization
8%
DNA Damage
7%
Mitosis
7%
Signal Transduction
7%
T Cell
7%
Clinical Study
7%
Gemcitabine
7%
Molecular Mechanism
7%
Guanine Nucleotide Exchange Factor
6%
Interferon
6%
Targeted Therapy
6%
Secretion (Process)
6%
Conjugate
6%
Ubiquitin-Conjugating Enzyme
6%
B Cell
6%
Tumor Immunity
6%
Isoform
6%
RNA
6%
Immunoassay
5%
Clonal Evolution
5%
Enzyme
5%
HDAC6
5%